Progressive Strength Training in Spinal Muscular Atrophy
- Conditions
- Muscular Atrophy, Spinal
- Registration Number
- NCT01233817
- Lead Sponsor
- University of Utah
- Brief Summary
The proposed feasibility study is necessary to test if children and young adults will participate in and adhere to a 12-week, home-based, supervised progressive strength training exercise program and to obtain preliminary data that will subsequently allow us to determine the safety and impact of strength training in spinal muscular atrophy. Our pilot study will address 3 aims: (1) Ascertain the feasibility of, and potential barriers to, participation in and adherence to a 12-week home-based, supervised, progressive strength training exercise program in children and young adults aged 5-21 years with SMA types II and III; (2) Determine the safety and tolerability of progressive strength training in a pilot study sample of children and young adults with SMA types II and III; and (3) Determine candidate outcome measures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 12
- age 5-21 years
- diagnosis of SMA type II or III
- at least antigravity strength in elbow flexors
- ability to follow commands and stay on task
- place of residence within a 60-minute or 60-mile drive of the University of Utah
- planned surgery or out-of-town trips during the proposed intervention period
- inability to travel to study center for testing
- neurological diagnosis other than SMA
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Strength 12 weeks Primary Outcome Measure was muscle strength. Strength was measured using a fixed myometry evaluation, quantitative muscle analysis (QMA). QMA utilizes a relative fixed point for the participant to exert effort. Each muscle of interest was tested using QMA.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Utah
🇺🇸Salt Lake City, Utah, United States
University of Utah🇺🇸Salt Lake City, Utah, United States